6TF-30807-63147
2 vaccinations
3 coded responses
15 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 199 / DE
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-27
- 2021-03-06
- 2021-03-13
-
2021-03-20
Survey response — day 28, dose 2MedDRA: Asthma, Cough, Pre-existing disease, Respiratory tract congestion — Feeling: FairFree text: Chest congestion, cough, asthma flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-04-03
-
2021-05-22
Survey response — 3 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-22
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-21
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-21
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-22 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-02-20 | Successful 2022-02-21 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 6 — day 28, dose 2
Symptoms: Chest congestion, cough, asthma flare
Release 8 — 3 months, dose 2
Symptoms: COVID
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release